BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
summarizeSummary
BrightSpring Health Services reported robust fourth quarter and full year 2025 financial results, significantly exceeding prior year performance. For Q4 2025, net revenue increased 29.3% to $3,551 million, and net income surged to $49.6 million from $4.3 million in Q4 2024. Full year 2025 saw net revenue grow 28.2% to $12,911 million, with the company swinging to a net income of $104.8 million from a net loss of $68.9 million in 2024. Adjusted EBITDA also showed strong growth, up 40.7% for the quarter and 34.2% for the full year, alongside a notable improvement in leverage from 4.16x to 2.99x. The company also initiated full year 2026 guidance and repurchased $43.2 million in shares. These strong results, including significant profitability and leverage improvements, indicate solid operational execution and financial health, likely reinforcing investor confidence, especially as the stock trades near its 52-week high. Traders will be watching the market's reaction to the specific 2026 guidance and the upcoming divestiture of the Community Living business.
在该公告发布时，BTSG的交易价格为$40.60，交易所为NASDAQ，所属行业为Life Sciences，市值约为$72.4亿。 52周交易区间为$15.48至$41.40。 这则新闻被评估为积极市场情绪，重要性评分为9/10。 来源：GlobeNewswire。